Clinical trial
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or…
NCT00003908 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003908 |
|---|---|
| Title | S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer |
| Official title | Evaluation of the Combination of Docetaxel (Taxotere)/ Carboplatin in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel |
| Enrollment | 68 |
| Start date | Nov 1, 1999 |
| Primary completion | Jun 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | May 21, 2004 |
| Last update posted | Apr 18, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: